Sponsored by: Fujifilm

Video from ISMRM 2019: Dr. Elizabeth Morris on diversity and inclusion

May 15, 2019
Latest in MRI
Fda
FDA warns Zoll Medical over MRI ventilator safety lapses
June 17, 2026
Cat Eye Nail Polish In Mri June2026
Metallic and cat-eye nail polish in MRI
June 17, 2026
Dollars Pile
AIRS Medical secures investment funds from TA Associates
June 16, 2026
The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnails
Podcast: Update on state-level responses to Long Island MRI accident
June 16, 2026
Related Stories
2019 05 10 21 30 8434 Canada Montreal Skyline 400
MRI
ISMRM: Opt for mpMRI to assess leg muscle microtrauma
2019 05 14 20 16 6958 Ismrm 2019 Ye Jong Chul 400
MRI
Video from ISMRM 2019: Jong Chul Ye on machine learning and data reconstruction
2019 05 10 21 30 8434 Canada Montreal Skyline 400
MRI
ISMRM: Deep learning moves toward clinical practice
2019 05 14 20 16 6802 Ismrm 2019 Erickson Bradley 400
MRI
Video from ISMRM 2019: Dr. Bradley Erickson on machine learning and clinical MRI
More in MRI
FDA warns Zoll Medical over MRI ventilator safety lapses
By AuntMinnie.com staff writers
MRI compatibility testing was performed using only a 3-tesla scanner, with no documented rationale for the omission of 1.5-tesla testing.
June 17, 2026
Fda
Metallic and cat-eye nail polish in MRI
By Kristin Seitz, Tobias Gilk
What MRI technologists need to know when they encounter metallic cat-eye nail polish in the clinic.
June 17, 2026
Cat Eye Nail Polish In Mri June2026
AIRS Medical secures investment funds from TA Associates
By AuntMinnie.com staff writers
The funding will support global expansion and product development.
June 16, 2026
Dollars Pile
Podcast: Update on state-level responses to Long Island MRI accident
By Liz Carey
As the McAllister story draws to a soft close, what's next?
June 16, 2026
The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnails
MRI scans link poverty, not IQ, to children's brain differences
By Kate Madden Yee
Socioeconomic conditions leave the deepest imprint on brain function of any factor, researchers reported.
June 15, 2026
Am 2019 02 20 20 38 9544 Mri Brain Head 400
Bayer nets FDA approval for Ambelvist low-dose MRI contrast agent
By AuntMinnie.com staff writers
Bayer has received FDA approval for its macrocyclic gadolinium-based contrast agent for contrast-enhanced MRI.
June 15, 2026
Bayer Rsna 2019 400
Experts propose new MRI standards for prostate cancer screening
By Kate Madden Yee
The guidance is intended to provide consensus on the acquisition, interpretation, and reporting of prostate MRI.
June 11, 2026
Am 2016 10 04 11 38 34 158 Prostate 400
AI gives a boost to cardiac MRI risk prediction
By Kate Madden Yee
Accurate risk prediction for coronary heart disease helps clinicians guide patient therapy and follow-up.
June 10, 2026
C-index for Cox regression and random survival forests models using two feature sets. Adding historical registry data decreases the C-index for Cox regression but increased it for the random survival forests model, consistent with the non-linear structure in the registry data.
fMRI reveals postmenopausal brain connectivity shifts in midlife women
By Kate Madden Yee
The findings suggest that menopause represents "an important neurological transition," researchers noted.
June 9, 2026
Network-level analysis comparing functional association strength between ROIs of pre- and postmenopausal groups. Lower levels of connectivity were identified among one cluster (F3,106 = 8.84, Puncorrected < 0.001, PFDR = 0.012) in the postmenopausal group, which included the right supramarginal gyrus anterior division, right planum temporale, and right Heschl’s gyrus, among others. FDR, false discovery rate; ROI, region of interest.
MRI finds perfusion defects across a range of lung impairments
By Kate Madden Yee
Impaired lung function is associated with increased pulmonary perfusion defects detectable by a particular MRI technique.
June 4, 2026
Caption: Representative images show emphysema and functional lung maps derived by CT and PREFUL-MRI: (A–C) CT-derived emphysema images, (D–F) perfusion maps, (G–I) regional ventilation maps, (J–L) flow-volume loop correlation metric maps, (M–O) ventilation/perfusion combined parameter maps. (A, D, G, J, M) Images in a 63-year-old male with normal spirometry: FEV1%pred = 89.0%, FEV1/FVC = 0.73; emphysema percentage = 0.2%, QDP = 7%, VDPRVent = 2%, VDPFVL-CM = 1%. (B, E, H, K, N) Images in a 65-year-old female with PRISm + RP: FEV1%pred = 71.2%, FVC %pred = 76.8%, FEV1/FVC = 0.76; emphysema percentage = 4.7%, QDP = 10%, VD-PRVent = 18%, VDPFVL-CM = 6%. (C, F, I, L, O) Images in a 57-year-old male with AO: FEV1%pred = 56.8%, FEV1/FVC = 0.52; emphysema = 11.1%, QDP = 31%, VDPRVent = 33%, VDPFVL-CM = 41%. AO = airflow obstruction, FEV1 = forced expiratory volume in 1 second, FVC = forced vital capacity, FVL-CM = flow-volume loop correlation metric, %pred = percent predicted, PREFUL = phase-resolved function lung, PRISm = preserved ratio impaired spirometry, QDP = perfusion defect percentage, RVent = regional ventilation, VDP = ventilation defect percentage.
Image-guided focal laser ablation effective for prostate cancer
By Amerigo Allegretto
MRI-directed, ultrasound-guided TPLA may be a promising technique to treat prostate cancer while avoiding radical therapies.
June 3, 2026
Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).
Podcast: Telltale signs your MRI safety standards are inadequate
By Liz Carey
Check your MRI safety sense.
June 2, 2026
The Invisible Force Podcast Album Cover Auntminnie Jan 2026 Thumbnails
Page 1 of 646
Next Page